⌘K

Login Start Free

Home/Filings/4/0001209191-22-041605

4//SEC Filing

Mandell Art 4

Accession 0001209191-22-041605

CIK 0001287098other

View on SEC.gov Company Profile

Filed

Jul 7, 8:00 PM ET

Accepted

Jul 8, 4:02 PM ET

Size

5.5 KB

Accession

0001209191-22-041605

Insider Transaction Report

Form 4

Period: 2022-06-29

MAXCYTE, INC.MXCT

Director

Transactions

Award
Stock Option (right to buy)
2022-06-29+26,900→ 26,900 total
Exercise: $4.82Exp: 2032-06-28→ Common Stock (26,900 underlying)

Footnotes (1)

[F1]This annual option grant was made pursuant to the Issuer's Equity Grant Policy for non-employee directors. The shares underlying this option vest on June 29, 2023, subject to the reporting person's continuous service as of such vesting date.

Documents

1 file

4
doc4.xmlPrimary
FORM 4 SUBMISSION

Issuer

MAXCYTE, INC.

CIK 0001287098

Entity typeother

Related Parties

1

filerCIK 0001874506

Filing Metadata

Form type: 4
Filed: Jul 7, 8:00 PM ET
Accepted: Jul 8, 4:02 PM ET
Size: 5.5 KB

View on SEC.gov